Abstract
Multiresponse optimization methodology in combination with experimental design was employed as a powerful technique for simultaneous optimization of input variables significant for evaluation of chromatographic behaviour of zolpidem tartrate, zolpacid, oxozolpidem, zolpyridine and zolpaldehyde towards various responses. In the first stage of the investigation fractional factorial design was used to decrease the number of variables that should be studied in detail. Among examined variables, pH of the mobile phase, percentage of organic modifier and buffer concentration showed to be statistically important and were consequently optimized with central composite design and Derringer’s desirability function. Four responses were considered, the retention factors of zolpacid and zolpaldehyde (the first and last peak) and the resolutions between critical peaks. Optimal conditions included Luna C18(2) analytical column (250 mm x 4.6 mm, 5 μm particle size), mobile phase consisted of methanol–10 mM ammonium acetate (68.4:31.6, v/v, pH 5.4) and column temperature of 35 °C. The flow rate of the mobile phase was 1 mL min−1 and the detection was performed at 254 nm. At the end, the method was successfully validated in accordance with ICH guideline and subsequently applied to the analysis of commercially available zolpidem tartrate tablets.
Similar content being viewed by others
References
Sweetman SC (ed) (2009) Martindale: the complete drug reference 36. Pharmaceutical Press, London
Dollery C (ed) (1999) Therapeutic drugs, 2nd edn. Edinburgh, Churchill Livingstone
ICH Q3B (R2) (2003), revision included (2006) Fed Regist 68:64628–64629
Ring PR, Bostick JM (2000) J Pharm Biomed Anal 22:495–504
Nirogi RVS, Kandikere VN, Shrivasthava W, Mudigonda K (2006) Biomed Chromatogr 20:1103–1108
Ptacek P, Macek J, Klima J (1997) J Chromatogr B 694:409–413
Ascalone V, Flaminio L, Guinebault P, Thenot JP, Morselli PL (1992) J Chromatogr 581:237–250
Tracqui A, Kintz P, Mangin P (1993) J Chromatogr 616:95–103
Wang Q, Sun L, Lau CE (1999) J Chromatogr B 734:299–305
Villain M, Cheze M, Tracqui A, Ludes B, Kintz P (2004) Forensic Sci Int 143:157–161
Giroud C, Augsburger M, Menetrey A, Mangin P (2003) J Chromatogr B 789:131–138
Kintz P, Villain M, Ludes B (2004) J Chromatogr B 811:59–63
Bhatt J, Jangid A, Shetty R, Shah B, Kambli S, Subbaiah G, Singh S (2006) Biomed Chromatogr 20:736–742
Stanke F, Jourdil N, Bessard J, Bessard G (1996) J Chromatogr B 675:43–51
Gaillard Y, Gay-Montchamp JP, Ollagnier M (1993) J Chromatogr 622:197–208
Keller T, Schneider A, Tutsch-Bauer E (1999) Forensic Sci Int 106(2):103–108
Winek CL, Wahba WW, Janssen JK, Rozin L, Rafizadeh V (1996) Forensic Sci Int 78:165–168
Hempel G, Blaschke G (1996) J Chromatogr B 675:131–137
El Zeany BA, Moustafa AA, Farid NF (2003) J Pharm Biomed Anal 33:393–401
Laviana L, Mangas C, Fernandez-Mari F, Bayod M, Blanco D (2004) J Pharm Biomed Anal 36:925–928
Council of Europe (2008) European Pharmacopoeia, 6th edn. Council of Europe, Strasbourg
Preu M, Guyot D, Petz M (1998) J Chromatogr A 818:95–108
Martendal E, Budziak D, Carasek E (2007) J Chromatogr A 1148:131–136
Ferreira SLC, Bruns RE, Paranhos da Silva EG, Lopes dos Santos WN, Quintella CM, David JM, Bittencourt de Andrade J, Breitkreitz MC, Jardim ICSF, Neto BB (2007) J Chromatogr A 1158:2–14
Nowak M, Seubert A (1999) J Chromatogr A 855:91–109
Bezerra MA, Santelli RE, Oliveira EP, Villar LS, Escaleira LA (2008) Talanta 76:965–977
Zecevic M, Jocic B, Zivanovic Lj, Protic A (2008) Chromatographia 68:911–918
Candioti LV, Robles JC, Mantovani VE, Goicoechea HC (2006) Talanta 69:140–147
Safa F, Hadjmohammadi MR (2005) J Chromatogr A 1078:42–50
Ortiz MC, Herrero A, Sanllorente S, Reguera C (2005) Talanta 65:246–254
Jeong IJ, Kim KJ (2009) Eur J Oper Res 195:412–426
Sivakumar T, Manavalan R, Muralidharan C, Valliappan K (2007) J Pharm Biomed Anal 43:1842–1848
Zivanovic Lj, Protic A, Zecevic M, Jocic B, Kostic M (2009) J Pharm Biomed Anal 50:640–648
Candioti LV, Olivieri AC, Goicoechea HC (2007) Anal Chim Acta 595:310–318
ICH Q2 (R1) (1997) addendum incorporated (2005) Fed Regist 62:27463–27467
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Malesevic, M., Zivanovic, L., Protic, A. et al. Multiobjective Optimization Approach in Evaluation of Chromatographic Behaviour of Zolpidem Tartrate and Its Degradation Products. Chromatographia 74, 197–208 (2011). https://doi.org/10.1007/s10337-011-2064-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-011-2064-9